Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
186M
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
69M
-
Shares change
-
+1.94M
-
Total reported value, excl. options
-
$1.9B
-
Value change
-
+$49.8M
-
Put/Call ratio
-
1.02
-
Number of buys
-
47
-
Number of sells
-
-55
-
Price
-
$27.51
Significant Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q3 2021
141 filings reported holding RVMD - Revolution Medicines, Inc. - Common Stock as of Q3 2021.
Revolution Medicines, Inc. - Common Stock (RVMD) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 69M shares
of 186M outstanding shares and own 37.04% of the company stock.
Largest 10 shareholders include FMR LLC (7.8M shares), VANGUARD GROUP INC (6.24M shares), TRV GP III, LLC (5.52M shares), BlackRock Inc. (5.11M shares), WELLINGTON MANAGEMENT GROUP LLP (4.54M shares), BOXER CAPITAL, LLC (3.48M shares), Bellevue Group AG (3.46M shares), Cormorant Asset Management, LP (3.14M shares), STATE STREET CORP (2.81M shares), and Casdin Capital, LLC (2.8M shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.